Psihoplastia căii mezolimbice în adicții – algoritmul de remodelare a căii recompensei

Introduction

In recent years, the major discovery in the field of addictions has been the identification of the reward circuit (pleasure pathway) – the cortico-mesolimbic circuit⁽¹⁾. It seems that the dopaminergic mechanism at the level of this circuit, with connections to the frontal cortex and higher cognitive centers, is responsible for addictive behaviors⁽²⁾. The dopaminergic theory of addictions follows the model of pleasure seeking (hedonic)⁽³⁾. Dopamine is a neuromediator responsible for cognitive functioning – modulation of attention, learning and memory capacity, planning, motivation and attachment (and it seems to mediate desire)⁽²⁾. Thus, addictions are basically the result of a pathological, distorted learning process⁽⁴⁾. We thus understand that no substance or behavior generates addiction if it is not repetitive and predictable. At first, the reward is sought, the “pleasure” that the contact with the respective substance or activity generates. The physical support of pleasant sensations is mainly constituted by the massive release of dopamine⁽¹⁾. Dopaminergic circuits are those that encode reward, naturally being activated by stimuli important for survival.

Similar to natural stimuli, addictive drugs or alcohol suddenly trigger messages in the reward system, messages that, through intensity and repetition, exceed the usual levels of activation. Unlike natural rewards (tasting your favorite food, being awarded, running, etc.) in which the release of dopamine is gradual, the drugs produce a quasi-instantaneous explosion of dopamine in the brain – here and now⁽²⁾. The cortical circuits involved are brutally unbalanced, which triggers adaptive reactions in functionally connected structures. These reactions are initially transient, but with repetition they become permanent – the brain tries to maintain its homeostasis (balance) and limit the imbalance. Progressively, the pleasure produced by the drug decreases⁽⁵⁾. That is why it is said that the consumer/addict is always looking for the first sensation given by the drug. And never finds it again.

The good news is that the pleasure pathway (reward pathway) can be reshaped. Everything you learn has unlearning. You can relearn to enjoy the things that bring you pleasure naturally. Relearn to enjoy natural stimuli, healthy rewards – enjoy relationships, read a book, travel or savor personal success, etc. You can rediscover to enjoy life.

In scientific, medical terms, we have called the process psychoplasty of the mesolimbic pathway or psychoplasty of the reward circuit. It actually means remodeling the pleasure pathway, the process by which you rediscover to enjoy natural rewards, with the reinstatement of self-confidence and a true mental reshaping.

This remodeling process involves training exercises of the prefrontal cortex, using noninvasive, natural dopaminergic fitness methods.

The concrete steps to achieve this include general elements of nutrition modulation, adapting physical exercises that come with an intake of endorphins, the development of body image and self-image, social skills training and personal evolution.

Concept definition: psychoplasty of the mesolimbic pathway in addiction

Mesolimbic pathway psychoplasty (or reward circuit remodeling) refers to the brain’s intrinsic capacity to modify its physical structure, synaptic connections and neurochemical function within the ventral tegmental area (VTA) – nucleus accumbens (NAc) axis, as a direct result of chronic substance use or addictive compulsive behaviors⁽⁴⁾.

In addictions, this plasticity is pathological (maladaptive) – negative psychoplasty.

The mechanism of pathological remodeling

The negative psychoplasty process involves two major phases.

Initial hyperexcitability (pathological learning): substances/behaviors trigger a massive, artificial dopamine release in the NAc⁽²⁾. This forces the brain to “learn” that this stimulus is vital, creating exaggerated incentive salience (intense craving⁽³⁾). Synapses strengthen to prioritize this stimulus⁽⁴⁾.

Homeostatic neuroadaptation (tolerance and anhedonia): to protect itself from overstimulation, the brain reduces its sensitivity. It appears a D2 receptor downregulation with fewer dopamine receptors available. We witness a decreased basal dopamine production, as the brain no longer produces enough dopamine for natural rewards (food, social interaction)⁽⁵⁾.

As a result, the individuals enter a state of reward deficiency syndrome – they can no longer experience pleasure from anything else, needing the substance just to feel “normal”⁽⁶⁾.

In our algorithm of therapeutic remodeling (psychoplasty or positive psychoplasty), remodeling is not just abstinence, but an active process of:

• reversing adaptations – through sustained abstinence and therapy, the brain slowly begins to re-grow the number of dopamine receptors⁽⁵⁾;
• functional “re-wiring” – using techniques like contingency management (tangible rewards for positive behaviors) or physical exercise forces the mesolimbic pathway to respond once again to natural, low-threshold stimuli, restoring dopaminergic balance⁽⁴⁾.

We propose as first step using the multidimensional assessment of the ASAM 2024 (4^th Edition)⁽⁷⁾.

Dimension 1: Acute intoxication and/or withdrawal potential – immediate risk of severe withdrawal (e.g., seizures, delirium tremens).

Dimension 2: Biomedical conditions and complications – physical health issues (diabetes, liver disease, infections) that can complicate addiction treatment or are worsened by use.

Dimension 3: Psychiatric, cognitive and emotional conditions and complications – dual diagnosis (depression, anxiety, PTSD) and the patient’s capacity to understand and participate in treatment (cognitive function).

Dimension 4: Substance use-related risks – the likelihood of continued use and associated immediate dangers (overdose, risky behavior).

Dimension 5: Recovery environment – support resources, housing stability and exposure to social networks the patient use.

Dimension 6: Person-centered considerations (updated 2024) – barriers to care. It includes cultural factors, logistics (transportation, childcare) and specific traumas that may hinder treatment adherence.

This assessment is no longer just a checklist; it is a risk management process across six revised dimensions, targeting to evaluate the complexity of addiction problems and helping clinicians to objectively refer the patient to an appropriate level of care.

To visualize the process, imagine the following decision flow⁽⁸⁾:

• Data collection – structured clinical interview across the six dimensions.
• Risk scoring – for each dimension, assign a risk level (0 = minimal, 4 = extremely severe).
• Identification of service needs – what specific interventions are needed for each dimension (e.g., detoxification, trauma-informed therapy, social assistance).
• Determination of level of care (LOC) – select the treatment level (from 0.5 – prevention, to 4).
• Medically managed intensive inpatient, that can address the most severe risk identified.

In Step 2, we use a neurobiological scoring and classification.

The results from Step 1 are used to categorize the patient’s driving addiction mechanism into one of two distinct neurobiological phenotypes based on symptom dominance⁽⁹⁾.

Path 1: Impulsivity (pleasure seeking)

• Underlying scale – high score on the ICDS (Impulsivity Dissociation Scale).
• Neurobiology – involves the nucleus accumbens (NAc) and ventral tegmental area (VTA)⁽¹⁰⁾.
• Mechanism – driven by positive reinforcement; seeking a reward or euphoria⁽¹¹⁾.

Path 2: Compulsivity (avoidance of suffering)

• Underlying scale – high score on the OCDUS (Obsessive Compulsivity Drug Use Scale)⁽¹²⁾.
• Neurobiology – involves the extended amygdala and dorsal striatum⁽⁹⁾.
• Mechanism – driven by negative reinforcement; avoidance of withdrawal symptoms, stress or emotional suffering⁽¹³⁾.

Step 3: Psychoplasty therapy plan

The final step tailors a combined treatment approach (psychotherapy and pharmacotherapy) based on the path identified in Step 2.

Therapy for impulsivity (Path 1)

Anatomical targets: nucleus accumbens (NAc) and prefrontal cortex (PFC).

Psychotherapy, such as contingency management (CM), uses non-substance rewards/vouchers to outcompete the addictive substance⁽⁴⁾.

Pharmacotherapy, such as naltrexone (or other opioid antagonists), blocks the euphoric dopamine spikes to reduce reward-seeking behavior⁽¹⁾.

Therapy for compulsivity (Path 2)

Anatomical targets: dorsal striatum and amygdala.

Psychotherapy, such as CBT and ACT for relapse prevention, focuses on breaking automatic habits and managing stress/negative reinforcement⁽¹⁰⁾.

Pharmacotherapy, such as buprenorphine (or other partial agonists), stabilizes neurotransmitters, reduces withdrawal/cravings and calms the overactive amygdala⁽¹³⁾.

Using this algorithm, we are shifting from awareness to “neural engineering”. To move from understanding to remodeling, we focus on three pillars: repairing the “brake” (prefrontal cortex), calming the “alarm” (amygdala) and recalibrating the “compass” (the reward system)⁽²⁾.

1. Reconnecting the prefrontal cortex (PFC)

In addiction, PFC is “disconnected” from the impulse areas⁽²⁾. It is like having a Ferrari engine (impulses) with bicycle brakes.

Inhibition training: it’s not about raw “willpower”, it’s about the pause muscle. For example, the “Wait 15 minutes” exercise, when craving hits forces the PFC to send inhibitory signals to the lower brain centers⁽⁴⁾.

Top-down regulation: mindfulness practices are not just for relaxation; they are weightlifting for your PFC. You learn to observe the impulse without becoming the impulse.

2. Remodeling the reward pathway (VTA → nucleus accumbens)

The core issue in addiction is dopamine homeostasis⁽⁵⁾. The brain has downregulated its dopamine receptors to protect itself from massive artificial dopamine spikes. This is why natural things stop feeling rewarding⁽⁶⁾.

Dopamine fasting: it allows receptors to desensitize and rebuild. This is the period of “therapeutic boredom”.

Micro-rewards: re-training the brain to appreciate small, natural rewards. Completing a minor task, taking a walk, or having a real conversation triggers small dopamine releases that “repair” the circuit.

Because the prefrontal cortex is heavily taxed during the day for executive functions, decision-making and emotional regulation, it is highly dependent on this deep sleep cleanup. If deep sleep is cut short, the buildup of these metabolic wastes immediately impairs the PFC the next day, leading to brain fog, emotional reactivity and poor risk assessment⁽²⁾.

Addiction has built solid neural “highways”. We cannot instantly erase them, but we can build new “national roads” through positive psychoplasty⁽⁴⁾. With repeated use, these new roads will become the brain’s default route.

Addiction completely disconnects the brain’s brake (PFC) from the impulse engine⁽²⁾. Because of heavy dopamine surges, your dopamine receptors are eventually “silenced” (downregulation)⁽⁵⁾. The engine is revving, but the brakes are cut.

Changing brain isn’t magic; it is applied biology. Actually, you don’t have wait to “feel motivated” to start. Motivation is a byproduct of action, not its fuel. Start with a 15-minute pause between impulse and reaction. Build your infrastructure of freedom, neuron by neuron.

We often hear that nothing can be done, that it is immersed in consumption, and that it is a lost cause. We are not a fan of providential, generally valid solutions. But nowadays, with tremendous progress in knowledge and neurobiology of addiction, there is always something that can be done, and experience shows us that the potential for change, for metamorphosis, is admirable.

In synthesis, nowadays, with the help of an addiction specialist, we can truly approach personalized remodeling, reshaping of reward pathway, with objective positive changes in the course of addiction patient.

Autor corespondent:  Ovidiu Alexinschi E-mail: alexinschi@yahoo.com

CONFLICT OF INTEREST: none declared.

FINANCIAL SUPPORT: none declared.

This work is permanently accessible online free of charge and published under the CC-BY.